Biotrial

Solutions & Services
Solutions & Services
Preclinical

Safety

Efficacy

PK Studies

Model Development

Core Lab

Central EEG & Polysomnography

CNS Testing

Cardiac Safety & ECG

QT Investigations

Medical Imaging

Clinical

Phase 1 Healthy Volunteers

Specialized Phase 1 studies

Oncology Trial Management

Patient Trial Management

Clinical Monitoring

Pharmacovigilance & Medical Monitoring

Pharmaceutical Affairs

Regulatory Affairs

Bioanalysis

Non-GLP & Discovery Services

Method development & Method Transfer

GLP Preclinical Sample Analysis

Quantitative Bioanalysis using LC-MS MS

Sample Management & Storage

Biometrics

EDC (Electronic Data Capture)

Data Management

Biostatistics

Medical Writing
Therapeutic Areas
About Us
About Us
About Us

History

Mission

Our locations

Biotrial

Contact

Solutions & Services Ouvrir
- Preclinical
  - Safety
  - Efficacy
  - PK Studies
  - Model Development
- Core Lab
  - Central EEG & Polysomnography
  - CNS Testing
  - Cardiac Safety & ECG
  - QT Investigations
  - Medical Imaging
- Clinical
  - Phase 1 Healthy Volunteers
  - Specialized Phase 1 studies
  - Oncology Trial Management
  - Patient Trial Management
  - Clinical Monitoring
  - Pharmacovigilance & Medical Monitoring
  - Pharmaceutical Affairs
  - Regulatory Affairs
- Bioanalysis
  - Non-GLP & Discovery Services
  - Method development & Method Transfer
  - GLP Preclinical Sample Analysis
  - Quantitative Bioanalysis using LC-MS MS
  - Sample Management & Storage
- Biometrics
  - EDC (Electronic Data Capture)
  - Data Management
  - Biostatistics
  - Medical Writing
Therapeutic Areas
About Us Ouvrir

Corporate

Biotrial 2023 annual newsletter

From breakthrough MESHCAP project advancements to our commitment to growth through the Boost 2030 plan, Biotrial’s 2023 was a testament to excellence and innovation.

Download the 2023 newsletter

Back to news

Participate in a clinical trial

Volunteer in France

Volunteer in USA

Contact

Scroll to top